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1. Introduction   
Since ancient times, the mushrooms have been prized as food as well as source for drugs, 
giving rise to an increasing interest today ("functional food"). Number of macrofungi is of a 
medicinal importance and represents an unlimited source of secondary metabolites of high 
medicinal value while a large number of biologically active molecules are identified in many 
species of macrofungi throughout the world (Wasser & Weis, 1999; Kitzberger et al., 2007; 
Barros et al., 2007; Turkoglu et al., 2007; Kim et al., 2008; 2007; Wasser, 2011). In addition, of 
importance is the amount of produced substances namely, they must be simple for the 
manufacturing (industrial synthesis) or there must be enough raw material for extraction of 
active molecules. Such molecules, if chemical groups responsible for biological activity are 
known, should serve as basic compounds for the synthesis of new molecules. 
Lignicolous macrofungi express significant biological effects, including antibacterial activity 
(Hur et al., 2004; Ishikawa et al., 2005; Kalyoncu et al., 2010) and their secondary metabolites 
can be easily extracted and identified. It has been found that secondary metabolites are very 
divergent in structure and play no essential role in their growth and reproduction, but 
probably have a function in biochemical evolution of a species ensuring its survival (Engler et 
al., 1998). The presence of these compounds in macrofungi is genetically determined, but also 
varies as a function of ecological factors and the growth stage of these organisms (Puttaraju et 
al., 2006). The fungal metabolites of fruiting bodies frequently differ from those of mycelia of 
submerged cultures or fermentation broth. Moreover, biogenetic pathways are rather 
dependent on their habitats or geographic origin. The chemical composition of fungal species 
significantly relies on the strains and sites (substrates) of the fruiting body production. The 
level of phenolic compounds seems to be very much dependent on the location and stress 
conditions (Kim et al., 2008). With regard to this, more geographical regions and more habitats 
should be analyzed in the future.  
A great potential of these fungi is found in their use as dietary supplements, regardless 
active principle. A number of products derived from mushrooms that are sold in the market 
is untested and of suspicious quality. Since the natural style of life become more and more 
popular around the world, what means return to the organic, natural food and medicines, 
many people lack a critical attitude to the so-called ecological products. It would therefore 
be important to develop food suplements and medicines based on natural resources, but 
with the necessary scientific confirmation of values of such products.  
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1.1 Macrofungi 
Macrofungi or mushrooms are not taxonomic categories, being most frequently used as 
terms for fungi with distinctive fruiting bodies, which are usually fleshy and edible, 
hypogeous or epigeous, large enough to be seen with the naked eye, and picked by hand 
(Chang and Miles, 2002, Karaman et al., 2012).  
Lignicolous (wood-decaying) macrofungi, mostly belonging to the Polyporaceae family, are 
easily noticed, collected and recognized in the field. Taxonomically, these fungi mainly 
belong to the phyla Basidiomycota and Ascomycota, including about 20,000 known species, 
widely distributed on Earth. Recent estimations suggest that even more than 1.5 million 
species of fungi exist on our planet and about 140,000 species belong to macrofungi. 
However, only 10% of them are explored and 16% are cultured (Chang & Miles, 2004; 
Mueller, Bills & Foster, 2004).   
1.2 Antibiotics and antimicrobial agents   
From the beginning until now, the humankind has always been faced with a problem of 
spreading of infectious diseases. Today, more than 150 compounds make arsenal of 
antimicrobial substances used in the treatment of infectious diseases. Antibiotics are defined as 
low molecular weight organic natural products (secondary metabolites or idiolites) made by 
microorganisms, which are active at low concentrations against other microorganisms. There 
are estimations that among 12,000 antibiotics known, approximately 55% are produced by 
Streptomyces, 11% by other Actinomycetes, 12% from other bacteria and 22% from 
filamentous fungi (Inouye et al., 2004). In its broadest definition an antibacterial is an agent 
that interferes with the growth and reproduction of bacteria. Unlike antibiotics, antibacterials 
are not used as medicine for humans or animals, but are now most commonly described as 
agents used to disinfect surfaces and eliminate potentially harmful bacteria found in products 
such as soaps, detergents, health and skincare products and household cleaners.   
Since Alexander Fleming`s discovery, in 1928, of the first antibiotic, called penicillin, 
produced by the mold Penicillium chrysogenum, a real revolution in medicine with a new era 
of antibiotics have started. Later, the entire group of β-lactam antibiotics (penicillins and 
cephalosporins) was discovered, followed by the Waxman`s discovery of streptomycin 
derived from Streptomyces bacteria, used in a treatment of tuberculosis), and then 
tetracyclines, quinolones, antifungal metabolites, antiparasitic substances and more recently 
antiviral drugs such as acyclovir. In 1971, the second significant antibiotic cyclosporin A and 
C were isolated from fungal organism Hypocladium inflatum gams (Tolypocladium inflatum) 
which is the asexual state of the pathogen of beetles Elaphocordyceps subsessilis (Petch) G.H. 
Sung, J.M. Sung & Spatafora). Its immunosupresive activity was revealed in 1976 by J.F. 
Borel and was approved for use 1983 in order to reduce the risk of organ rejection in 
transplant surgery (Upton, 2001 as cited in Giovannini, 2006). 
1.3 Antibiotic resistance and further perspectives 
Today, antibiotic resistance is a serious problem and antibiotics are losing their effectiveness 
what is especially important and have serious threats for humans whose health is already 
compromised by stress in modern way of life or by illness (HIV patients, 
immnocompromised persons that are under chemotherapy). Along with the increasing use 
of antibiotics and antibiotic agents, the resistance of bacteria to common and more 
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frequently used antibiotics increased, resulting in low respond to the antibiotic treatment. 
The existance of multidrug-resistant diseases, once felt to be under control, increased as 
well, tuberculosis, penicillin-resistant pneumonia, resistant malaria (the cause of death of 1.1 
million people in 1998), resistant strains of gonorrhea or dysentery caused by Shigella and 
Salmonella (2.2 million deaths in 1998).  
Public concern about infection has been expanded, resulting in a greater public use of a 
variety of antibacterial agents designed to remove disease-causing organisms from external 
surfaces before they can enter the body. Today, antibacterials may also be impregnated into 
sponges, cutting boards, carpeting, and children's toys. However, if used too frequently and 
indiscriminately, certain antibacterial agents, those that leave trace chemical residues and 
that target particular processes in the life cycle of bacteria, may select for resistant strains 
(http://www.tufts.edu/med/apua/about_issue/agents.shtml).  
Furthermore, no new class of antibacterial substances has been developed to combat infectious 
diseases since 1970 (WHO, 2000). It is therefore necessary to find some new compounds to 
fight against these resistant microorganisms. Then starts the parallel struggle against antibiotic 
resistance exhibited in the continuous screening of new natural resources of undiscovered 
antibiotics from the nature. In this manner, the potential of mushrooms have a great 
advantage, even in comparison to the bacteria. Nowadays it is much more complicated to find 
new pharmaceutical active substances by chemical synthesis than from the existing and 
unexplored natural resources. Screenings of biological activities have made great progress in 
exploring the rich unlimited and undiscovered natural products in order to use it for 
production of pharmaceutical and agrochemical products (Anke, 1989). Many organisms 
were studied as potentially new resources of undiscovered bioactive components, among 
which fungi from the phylum Basidiomycota gave the promising results. In the forties, the 
pioneers in such research were Anchel, Hervey, Wilkins et al. and Florey et al. 1949, who 
tested extracts derived from fruiting bodies and mycelia cultures of more then 2000 species, 
resulting in isolation of a tricyclic diterpene antibiotic (pleuromutilin from Pleurotus mutilus). 
During nineties of the last century many new structures and biological activities were detected 
(Anke, 1989). Since then, numerous studies have been performed. Today we are witnessing 
very important struggle not only against microorganisms but also against other human 
diseases such as cancer, viral and other diseases. 
1.4 Antimicrobial substances - Antibiotics from fungi and macrofungi  
Microbial metabolites and their derivatives play an important role in the development of 
medicines. The use of these metabolites has grown extensively over the past century, 
starting with the Fleming’s discovery of penicillin (1924), originally from Penicillium notatum 
filamentous micro-fungus, via Brotzu’s discovery of cephalosporins from another fungus, 
mold Cephalosporium acremonium (Acremonium chrysogenum now), until today when the 
Japanese clinics use 30 penicillin derivatives and about 49 derivatives of cephalosporin. 
Although the metabolites originating from fungi were the main targets of antimicrobial 
screening, these studies were interrupted for a short time by Waksman’s discovery of 
streptomycin (1945) originating from Actinomycetes. It is believed that the cause of the 
break helped by the fact that fungi often produce mycotoxins with pronounced cytotoxicity 
in humans and animals, and one example is the aflatoxin from the mold Aspergillus flavus, 
the most prominent cause of chronic hepatitis that leads to tumor malignancy. 
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However, in recent years the trend has changed and fungal metabolites have again attracted 
the attention of pharmacological research. This can be seen from the statistics presenting 
fungal metabolites increasingly important as bioactive agents and showing that the 
percentage of medicines versus the metabolites originating from actinomycetes are as it 
follows (according to the Journal of Antibiotics (I), Tokyo): 13 versus 66% (1983), 16 versus 
74% (1990), 38 versus 53% (1994) and 47 versus 44% (2000), while the percentage of 
metabolites originating from the bacteria remained at about 8%, except 1983 when it was 
21%. A similar tendency was observed for metabolites that are registered as patents in 
Japan, showing that the products from the fungi grew intensively: 11% (1983), over 21% 
(1990) to 36% (2000), and for the products from actinomycetes decreased sharply from 74% 
(1983), over 66% (1990) to 48% (2000). According to Tanaka and Omura (1993), 43% of more 
than 8000 new microbial metabolites were discovered thanks to Japanese scientists. It is 
possible that the abundance of secondary metabolites of fungi and actinomycetes, compared 
with bacteria and yeasts, is associated with the characteristics of the environment poor in 
nutrients. Nutritional limitation further induces secondary metabolism and production of 
various compounds, in order to exploit scarce nutrients in the best extent possible (Aldered 
et al., 1999). Taking into account the antibiotic screening, review of Inouye et al.,  2004 
showed that the number of antifungal metabolites increased significantly, anticancer 
metabolites - moderately, while the number of antibacterial metabolites decreased in the last 
ten years. However, the most significant increase was observed in bioactive metabolites of 
non-antibiotic mode of action, especially regarding the screening of inhibitors of cholesterol 
synthesis, of which 93% originated from fungi (Yagisawa, 2000).  
In this sense it is considered that the eukaryotic fungal metabolites in action in mammalian 
cells could have far fewer side-effects compared with prokaryotic metabolites. Cultures of 
micro-organisms usually contain complex mixtures of different compounds, small and large 
molecular weight, what makes a direct pharmacological screening more difficult, 
considering the fact that can easily be masked by the activity of other compounds in the 
mixture. Being sessile organisms, which are in their natural environment constantly exposed 
to the influence of different competitors (parasitic organisms), it is not surprising that many 
antibiotics are isolated from fungi (Lindequist et al., 2005). Although today, still only 
compounds originating from micro-fungi or synthetic medicines have been used, literature 
data pointing to higher fungi, macro-fungi, primarily Basidiomycetes as natural sources rich 
in new antimicrobial substances are infrequently found (Suay et al., 2000). 
As potential new sources of natural antibiotics, lignicolous mushrooms again become the subject 
of study (Smania et al., 2001). The fact that humans and animals share common microbial 
pathogens with fungi (E. coli, S. aureus and P. areuginosa) has prompted the thought that they 
produce compounds that may have similar effects in humans (Zjawioni, 2004). In Western 
Europe, the interest for this group of fungi start with the discovery of antibiotics (penicillin), 
when a group of scientists with their pioneering research of new antibiotics originating from 
macrofungi Basidiomycota, led by M. Anchel, A. Hervey, WH Wilkins and Kavanagh, started 
research of extracts and culture mycelia and fruit body of about 2000 species (Florey et al., 1949). 
This research has resulted in isolation of antibiotics three-cyclic diterpene pleuromutilin 
(Kavanagh et al., 1951) from Pleurotus mutilus species. Pleuromutilin has demonstrated its 
antibacterial activity by inhibiting bacterial protein synthesis by interacting with RNA (Lorenzen 
& Anke, 1998). After that, the first semisynthetic antibiotic tiamulin was produced together with 
valnemuline, used in veterinary medicine (Egger & Reinshagen, 1976) for the treatment of 
Mycoplasma infections in animals (Lorenzen & Anke, 1998). 
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Many studies have shown that macrofungi produce many interesting pharmacological 
substances. By comparing the number of studied fungi with those whose chemical and 
pharmacological effects are completely unknown, we realized that only a very small, even 
insignificant fraction of potentially active fungal substances are known. For instance, the 
illustrative example is the species Ganoderma lucidum, witnessing that each species contains 
many different active components. In addition, production of certain secondary metabolites 
may depend on the characteristics of the strains (isolates) or culture conditions. Therefore, 
many scientists coping with this problem are actually trying to find new active compounds to 
be used in the future. It is clear that only a small number of active compounds studied in vitro 
or in vivo on animals as biological models suits the needs of allopathic medicine, defined by 
chemical composition, precise dosing, toxicology, pharmacodynamics and clinical studies. 
Macrofungi need antibacterial and antifungal compounds to survive in their natural 
environment.  Since fungi and humans share common microbial pathogens (e.g. E. coli, S. 
aureus and P. areuginosa), antimicrobial compounds that are produced by fungi against 
microorganisms, can benefit to humans (animals).  Compounds of special interest are those 
that exhibit antibacterial activities against multiresistant bacterial strains (methicillin 
resistant S. aureus – MRSA or vancomycine resistant Enterococcus – VRE).  
According to a recent biological evaluation, more than 75% of screened polypores showed 
strong antimicrobial activity inhibiting mostly Gram-positive bacterial strains (B. subtilis, S. 
aureus and M. flavus). It was reported that new sesquiterpenoid hydroquinones produced by 
some species of the European Ganoderma genus, named ganomycins, inhibit the growth of 
methicillin-resistant S. aureus and other bacteria (Mothana et al., 2000).  
Based on our results of antibacterial screening, 60% methanol and 55% chloroform extracts 
reached a significant antibacterial activity, giving the diameter of inhibitory zone (>15mmØ) 
against one or more target bacteria. Gram –negative bacteria were less sensitive to the applied 
extracts than Gram-positive ones, except G. lucidum ethanolic extract (25mg/ml) against P. 
aeruginosa (h) and E. coli (ATCC 25922). Three extracts of lignicolous macrofungi P. betulinus, C. 
versicolor and G. lucidum showed a wide range of activities against all tested Gram-positive and 
some of Gram-negative bacteria, reaching MIC values mainly at a concentration of 17.5 
mg/ml. Unlike methanol, chloroform extracts did not show concentration dependence while 
the concept of a dose response phenomenon- hormesis (low dose stimulation and high dose 
inhibition) may be used for explanation of this phenomenon. The precise composition of 
examined extracts of fungi is unknown and can only be assumed that the effect of crude 
extracts, which are concentration dependent, is a consequence of complex interactions between 
cells and mixtures of compounds in the extracts (Karaman et al., 2009a).  
In a recent screening of antibacterial activity of water and methanol crude extracts of the species 
Meripilus giganteus against nine species of Gram-positive and four species of Gram- negative 
bacteria,  the most active extract was methanolic extract, inhibiting all the Gram–positive 
bacteria (mostly S. aureusan, Rh. equi, Bacillus) and only two Gram-negative ones, C. perfringens 
and P. aeruginosa, ATCC strains (Karaman et al., 2009b) The animal strains showed to be the 
most susceptible analyzed strains, indicating a possible application of this fungus against Gram-
positive bacterial infections in animals. Since water extract exhibited only a narrow antibacterial 
effect, we assumed that the obtained results could not be attributed to the compounds like 
proteins or polysaccharides. These results are in agreement with the literature data for similar 
polypore fungi (Lindequist et al., 2005; Zjawioni, 2004), demonstrated sterols and lanostanoid 
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terpenoids as well as phenolic compounds as the main active components responsible for the 
obtained activity (Turkoglu et al., 2007; Barros et al., 2007; Elmastas et al., 2007).  
1.4.1 Antiviral substances  
Presented antiviral activity of fungi is related to their whole, complex extracts, but also to 
the isolated compounds. Agents isolated from fungi can directly cause the inhibition of viral 
enzymes, the synthesis of viral nucleic acid, or adsorption and absorption of virus in 
mammalian cells. The most often small molecules are active in the direct antiviral effect, 
while the indirect effects are mediated by antiviral activity immunostimulative 
polysaccharides and other complex molecules (Zjawioni, 2004). 
1.4.1.1 Low molecular weight compounds with antiviral activity   
Several triterpenes from G. lucidum (ganoderiol F, ganodermanontriol and ganoderic acid 
and B) are active antiviral agents against HIV-1 virus. In vitro antiviral activity of influenza 
viruses type A and B was noticed in extracts of mycelium of mushroom Kuehneromyces 
mutabilis (Schaeff.: Fr.) (Singer & AH Sm.), while the extract and two isolated phenolic 
components from the mushroom Inonotus hispidus (Bull.; Fr.) P. Karst, as well as ergosterol 
peroxide, are present in many different fungal species. 
1.4.1.2 High molecular weight compounds with antiviral activity 
Water-soluble lignins isolated from Inonotus obliquus (Pers.: Fr.) Pilate, inhibit HIV protease 
with IC 50 value of 2.5 mg/ml. Anti-HIV activity is recorded for the submerged culture 
media of L. edodes and water-soluble lignin isolated from the same fungus. Protein-
polysaccharide complex PSK and PSP from Coriolus versicolor, also shows antiviral activity 
on HIV and cytomegalovirus in vitro. Inhibition of HIV-1 reverse transcriptase is caused by 
velutin, protein from Flammulina velutipes, which inactivates ribosomes. MD fractions of 
mushroom Grifola frondosa showed general improvement of condition of the patients (85%) 
who had various symptoms of HIV and other secondary diseases (Zjawioni, 2004). 
1.4.2 Antifungal substances 
Compounds with antibacterial and antifungal activity of mushrooms assists in their survival 
in their environment. These substances can be very useful in the treatment of human 
infections, but the official antibiotic therapeutics in the world market can be only found 
originating from microfungi so far. Opportunistic fungal infections are always a big problem, 
especially in immunocompromised patients receiving chemotherapy or in cases of 
transplantation of organs or bone marrow, as well as in HIV infection. During the last ten 
years, the interest in compounds that show antifungal activity has been increased. Among 
them the sordarin (tricyclic diterpene glycoside) was for the first time isolated in 1971 (Hauer 
and Sigg as cited in Inouye et al., 2004), and slightly more potent zofimarin was isolated for the 
first time in 1987 (Ogita et al. 1987 as cited in Inouye et al., 2004). In addition, suggestive is 
xylarin (compound SCH57404) isolated from the lignicolous fungus Xylaria sp. (Schneider, 
1995). Many derivatisations of sordarin antibiotics have been performed in research groups of 
the GlaxoSmith Kline company  by biotransformation with Streptomyces avermitilis, what 
resulted in the synthesis of GM237354 (Herreros et al., 1998), with the MIC of 90% that was 
0.015 mg/ml for isolates of C. albicans and 0.12 for C. tropicalis. Further development of these 
compounds has led to the azasordarin group in which the sugar component is replaced by N-
substituted morpholine (Herreros et al., 2001 as cited in Inouye et al., 2004). 
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Several antifungal metabolites with steroid structure have been also isolated from fungi 
A25822 A and B from Geotrichum (Gordee and Butler, 1975 as cited in Inouye et al., 2004) 
and from Wallemia sebi; Mer-NF8054 A and X from the genus Aspergillus. The most famous 
triterpene, favonol isolated from basidiomycetous Favolashia sp. (Anke et al., 1995 as cited in 
Inouye et al., 2004) is a metabolite that exhibited antifungal activity against Ascomycetes, 
Basidiomycetes, Zygomycetes and Oomycetes, but did not show antibacterial activity. 
Researchers of Merck Group have discovered four acidic terpenoids from filamentous fungi: 
ergokonin A (from Trichoderma koningii), ascosteroid (from Ascotricha amphitricha) arundifungin 
(steroid from Arthrinium arundinis) and enfumafungin (pentacyclic terpenoid from from 
mould Trichoderma koningii), ascosteroid (from ascomycetous Ascotricha amphitricha), 
arundifungin (steroid from mould Arthrinium arundinis) and enfumafungin (pentacyclic 
terpenoid from Aureobasidium), which were found to affect the biosynthesis of β-D-glucan but 
not the biosynthesis of steroids. Among them the best antifungal activity on Candida species 
and species of Aspergillus genera showed enfumafungin.  
1.5 Chemical nature of antibacterial agents 
A large number of pharmacologically active substances like sesquiterpenes (Abraham, 
2001), hydroquinones (Mothana et al., 2000), polysaccharides and complexes of 
polysaccharide-peptide (Liu, 1999), lanostanoide triterpenoids (Shiao, 1992, Leon et al., 2004) 
steroids (Smania, 2003), nucleosides, alkaloids and vitamins (Paterson, 2006) from 
fruitbodies of polypore fungi have been detected. Recent studies pronounced phenolic 
compounds (Turkoglu et al., 2007, Paterson, 2006, Ribeiro et al., 2007) as the main active 
antioxidative components in fungal extracts (Kityberger et al., 2007; Barros et al., 2007). It is 
assumed that antibacterial effects exhibited by fungal extracts of different polarites could be 
related to an overall effect of phenolic compounds (e.g. phenolic acids: caffeic acid, ellagic 
acid; flavonoids, hydroquinones) detected in similar extracts of the species G.lucidum, 
F.velutipes, P.ostreatus or organic acids (oxalic, malic) previously detected in L. sulphureus 
and F. hepatica,  as well as terpenoids.  
1.5.1 Products of primary metabolism  
Polysaccharides. Polysaccharide molecules that form an integral part of the fungal cell wall 
also exhibit antimicrobial properties (Stamets, 2002). Polysaccharides are the most important 
components of fungal bioactive substances, proven to provide many medical and therapeutic 
possibilities (Fan et al., 2006) while their antibiotic effect is often specific to certain 
microorganisms (Stamets, 2002). Most of these compounds belong to glucans or heteroglycans 
(Fan et al., 2006). It is believed that the antibacterial and antifungal effects of β-glucan is based 
on the activation and strengthening of the immune response, and their use is recommended in 
combination with other antibiotics and immunostimulators in prevention and treatment of 
infectious diseases, especially immunocompromised individuals (Chen & Seviour, 2007).  
Proteins and polypeptides. Proteins that act inhibitory on microorganisms are found 
frequently in organisms of plant and animal species, whereas their presence is rare in fungi 
(Wang & Ng, 2006). It is believed that these proteins are often positively charged, and that 
the mechanism of their action is realized by forming ion channels in cell membranes of 
microorganisms as well as by competitive binding to host cell polysaccharide receptors 
(Cowan, 1999). Proteins and peptides are isolated from macrofungi whose antimicrobial 
effect is limited to a small number of mostly phytopathogenic species (Table 1). 
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COMPOUNDS ORIGIN/SOURCE BIOLOGICAL ACTIVITY/REFERENCE 
EXTRACELULAR POLYSACCHARIDES (noncellulose β-glucans)
 
LENTINAN 
Lentinus edodes mycelial 
extract of Lentinus edodes
antifungal: Candida albicans,  
antibacterial: Mycobacterium tuberculosis, 
Listeria monocytogenes, S. aureus, M. luteus i 
B. cereus  (Stamets, 2002; Kitzberger et al., 
2007; Chen & Seviour, 2007) antiviral: 
Herpes simplex-a type 1 (Stamets, 2002) 
SCHYZOPHYLLAN (SPG) Schyzophyllum commune antifungal: Candida albicans, antibacterial: 
S. aureus. (Stamets, 2002)
KRESTIN (PSK), proteoglycan Trametes versicolor antifungal effect: C. albicans
(Stamets, 2002; Kitzberger et al., 2007) 
GRIFOLAN (GRN) Grifola frondosa
 Lepista nuda
INTRACELLULAR POLYSACCHARIDES - containing 1,6-α-D-galactopyranosyl units, substituted 
on O-2 position with α-L-fucopyranosyl or 3-O-α-D-manopyranosyl-α-L-fucopyranosyl units. Found 
only in fungi and concerned as a type of reserve materials (Fan et al., 2006)
FUCOGALACTAN CMP3   
(hydrosoluble heteroglucan)  
from the mycelium of 
Coprinus comatus  
not yet investigated (C. comatus showing 
antibacterial activity) (Fan et al., 2006). 
FUCOGALACTAN G. applanatum
MANOFUCOGALACTANES F. velutipes, Polyporus 
pinicola, P. fomentarius 
and P. igniarius
not yet investigated, concerned as a 
reserve material (Fan et al., 2006) 
FUCOMANOGALACTANS Laetiporus sulphureus
GANODERMIN  
protein,  
molecular weight ≈15 kDa 
Ganoderma lucidum 
 
antifungal to phytopathogens Botrytis 
cinerea, Fusarium oxysporum and 
Physalospora piricola (Wang & Ng, 2006) 
PLEUROSTRIN  
Peptide,  
molecular weight of 7kDa 
Pleurotus ostreatus 
 
antifungal effect : Fusarium oxysporum, 
Mycosphaerella arachidicola and Physalospora 
piricola (Chu et al., 2005)
LYOPHYLLIN   
aqueous solution of 
Lyophyllum shimeiji  
antifungal effect : Mycosphaerella 
arachidicola and Physalospora piricola 
(Takakura et al., 2001; Wang & Ng, 2006) 
TRICHOGIN 
peptide 
Tricholoma giganteum
 
antifungal activity against Fusarium 
oxysporum, Mycosphaerella arachidicola and 
Physalospora piricola, as well as inhibitory 
effect on HIV-1 reverse transcriptase (Guo et 
al., 2005)
ERYNGIN  
peptide,  
molecular weight of 10kDa 
Pleurotus eryngii
 
inhibition of Fusarium oxysporum and 
Mycosphaerella arachidicola, its N-terminal end 
shows certain similarity with  antifungal 
protein liophyllin (Wang & Ng, 2004) 
AGROCYBIN  
peptide,  
molecular weight of 9 kDa 
Agrocybe dura
 
A. cylindracea  
 
antibacterial effect against Gram + and 
Gram - bacteria: B. mycoides, B. subtilis, E. 
coli, Klebisiella pneumoniae, Mycobacterium 
pheli, M. smegmatis, Photobacterium fischeri, P. 
aeruginosa , S. aureus (Kavanagh et al., 1950) 
antifungal effect: Aspergillus niger, Gliomastix 
convoluta, Memnoinella echinata, Myrothecium 
verrucaria, Penicillium notatum, Phycomyces 
blackesleeanus, Stemphylium consortiale and 
Trichomonas mentagrophytes (Ngai et al., 
2005)
Table 1. Polysaccharides, proteins and peptides from macrofungi with antimicrobial effect 
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Dietary fibers. High molecular weight substances that are excreted without digestion and 
absorption from the human body are called dietary fibers (Mizuno, 1999). Mushrooms 
contain these substances, which are composed of β-glucan, chitin and heteropolysaccharide 
(pectin substances, hemicellulose, polyuronidase, etc..) in the range of 10-50% in dry weight 
of the substance. Since they absorb harmful substances, hindering their intestinal 
absorption, dietary fibers are effective in preventing colon and rectal cancers (Mizuno, 1999). 
Lectins. Lectins (Latin legere = to take, to choose) are defined as carbohydrate-binding 
proteins of non-immune origin which agglutinate cells or precipitate polysaccharides or 
glycoconjugates (Kawagishi, 1995). Many species of plants, animals and microorganisms 
contain lectins, but the fungal lectin is still not explicitely defined. So far, several lectins 
were isolated from mushrooms of the genus Polyporales: Grifola frondosa (GFL), Fomes 
fomentarius (FFL), Ganoderma lucidum (GLLs). Some are isolated from the fruit bodies and 
some from the mushroom mycelium. GFL is cytotoxic to HeLa cells, and its activity is 
explained by binding of lectins to carbohydrate parts of the cell by preventing aggregation 
of cells (Wasser & Weis, 1999). 
1.5.2 Products of secondary metabolism  
Secondary metabolites produced by a large number of macrofungi have great therapeutic 
significance. These compounds occur as intermediate products of primary metabolism, but 
most of them are classified according to the five major metabolic sources (Table 2,3,4). The 
most productive pathways of synthesis of secondary metabolites are polyketide and 
mevalonate pathways (Zeidman et al., 2005, from Giovaninni, 2006). 
1.5.2.1 Phenolic compounds 
Phenols are one of the largest classes of secondary biomolecules, which are characterized by 
the presence of aromatic rings with hydroxyl group bonded directly to an aromatic 
hydrocarbon group. Although they are firstly identified in plants (Cowan, 1999), their 
presence was also observed in fungi (Barros et al., 2008, Mattila et al., 2001, Karaman, 2002, 
Karaman et al., 2012a). In recent years, there was a causal relationship between the total 
content of these compounds with biological activities recorded in a large number of 
macrofungi (Barros et al., 2007), which include anti-inflammatory, antiallergic, anticancer, 
antihypertensive, antirheumatic and antibacterial activity. Antimicrobial properties of 
phenolics are explained by the presence of phenol hydroxyl groups, which number is in 
correlation with their toxicity toward microorganisms (Cowan, 1999). The possible 
mechanisms of their action include inhibition of extracellular microbial enzymes, 
deprivation of the substrates required for microbial growth or direct action on microbial 
metabolism through inhibition of oxidative phosphorylation, by sulfhydryl groups and 
some non-specific interactions (Cowan, 1999). 
It has been shown that the antimicrobial effects of extracts of mushroom Lactarius deliciosus, 
Sarcodon imbricatus and Tricholoma portentosum directly correlated with total content of 
phenols and flavonoids in them (Barros et al., 2007). Extracts of all three fungi showed 
antibacterial effects on Bacillus cereus and antifungal to Candida neoformans, while the extract 
of mushrooms Lactarius deliciosus and efficiency demonstrated against P. aeruginosa and 
Candida albicans. High content of phenols has been recorded in lignicolous fungi Meripilus 
giganteus, G. lucidum and Flammulina velutipes in the form of coumarins and tannins, as well 
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as in Ganoderma applanatum, where they were detected in the form of coumarins, flavonoids 
and tannins (Karaman, 2002, Karaman et al., 2005). Data on the antimicrobial action of these 
fungi also exist (Karaman et al., 2010). Analyses of extracts of the genus Ganoderma species 
shown the presence of polyphenolic compounds, and antimicrobial properties of these 
mushrooms explains the activity of compounds of hydrohynon composition - ganomycin A 
and B (Ofodile et al., 2005 as cited in Mothana et al., 2000). 
High concentrations of phenolic acids (> 1.0 mg / g), mainly a high concentration of gallic 
acid and protocatechuic, could be interpreted as anti-microbial activity of the following 
species: L. sulphureus, F. hepatica, P. ostreatus, F. velutipes and partially M. giganteus, which in 
antimicrobial screening showed moderate activity (Karaman, 2009b). Further studies of 
mechanisms of antimicrobial components originating from mushrooms could be suggested, 
including the influence of the protein compounds and organic acids such as oxalic acid, 
which accumulates in the fruit bodies of brown rot mushrooms, but also malic acid, ellagic 
acid, or some other compounds. 
Flavonoids are hydroxylated phenolic compounds (C6-C3 units associated with the 
aromatic core) and antimicrobial activity can be explained by their ability to create 
complexes with extracellular soluble proteins and polypeptides that builds cell wall of 
microorganisms, as well as disruption of the function of cell membrane (Cowan, 1999). 
There are only few data dealing with detection of flavonoids (rutin, chrysin, naringin, 
myrcetin and quercetin) in tericolous (Turkoglu, 2007; Baros et al., 2007) lignicolous fungal 
species (Kim et al., 2008, Jayakumar et al., 2009). Since flavonoids are phenolics that 
generally occur in plants acting as antioxidants, antimicrobials, photoreceptors, feeding 
repellants or UV protectors (Pietta, 2000) we assume that the presence of these metabolites 
in TP of fungi that generally are in tight connection with wood, could have impact on the 
expressed bioactivity. Recent studies conducted with mushrooms showed a positive 
correlation between the TP and antioxidant capacity (Turkoglu, 2007, Ribeiro, 2007), 
possibly due to their ability to chelate metals, inhibit lipoxygenase and scavenge free 
radicals. Plotting TP content versus antibacterial activity (Karaman et al., 2010), revealed a 
good positive correlation between these two parameters , showing higher values for MeOH  
than CHCl3 extracts against most of the bacteria. By comparing different strains of the same 
bacteria (S. aureus) it was concluded that the effect of TP upon the antibacterial activity may 
be strain specific.  
Worthy of note is the antibacterial activity of fungi against the multidrug-resistant strains of 
bacteria. New sesquiterpenoid hydroquinone from Ganoderma pfeiefferi Bres., called 
ganomycin (Mothana, et al., 2000) inhibit methicillin-resistant strains of Staphylococcus aureus 
and the growth of other, mainly Gram-positive bacteria. In addition, sterol-type compounds, 
isolated from the species  G. applanatum such as 5α-ergost-7-en-3β-ol, 5α-ergost-7, 22-dien-
3β-ol, 5.8-epidioxy-5α, 8α-ergost-6,22-dien-3β-ol and another new lanostanoid showed weak 
activity against many Gram + and Gram - bacteria. Oxalic acid is one of the substances 
responsible for the antimicrobial effects of mushroom Lentinula edodes (Berk.). Chloroform 
extract of mycelium L. edodes has bactericidal properties (Hirasawa et al., 1999). 
Tannins are complex polyphenolic compounds that are devided into the two groups: the 
hydrolizated (esters of phenolic acids and sugars), and condensed (constructed from 
flavonoid monomers). Antimicrobial activity of tannins is expressed due to their ability to 
link amino acids in proteins, inactivating adhesions, enzymes and transport proteins of cell 
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membranes of microorganisms (Cowan, 1999), as well as the formation of complexes with 
metal ions (Biradar et al., 2007). In addition, tannins could form complexes with 
polysaccharides, affecting microorganisms. 
The equivalent of tannic acid was detected in extracts of shiitake mushrooms (Lentinus 
edodes), which show the antibiotic effect against bacteria M. luteus and B. cereus and the 
fungus Candida albicans, while against the strains of E. coli and S. aureus  did not show the 
same activity (Kitzberger et al., 2007). While the focus of previous mycochemical (gr. 
myces=fungi) analysis of Pleurotus ostreatus was mainly put on the vitamins and minerals 
content, indicating a high nutritional value of mushrooms (Mattila et al., 2005), recent 
research revealed its exceptional antimicrobial and antioxidant effects that are associated 
with the presence of terpene and phenolic compounds (Iwalokun et al., 2007). The presence 
of phenols in the form of pyrocatechols, and flavonoids in the form of quercetin, was noted 
in extracts of fungus Laetiporus sulphureus, which explains its strong antioxidant properties 
(Turkoglu et al., 2006). This study also shows that ethanol extract of L. sulphureus exhibits 
strong antibiotic effect against Gram-positive bacteria (B. subtilis, B. cereus, M. luteus and M. 
flavus) and the yeast Candida albicans, while its activity against Gram-negative bacteria is 
much lower. 
Coumarins are phenolic compounds of characteristic odor, and, according to the chemical 
structure, they are lactones built from the benzene and pyrone ring (Cowan, 1999). Despite 
the antiviral activity of some coumarins and the evidence of their inhibitory effect on the 
fungus Candida albicans in vitro conditions (Cowan, 1999), data on antimicrobial activity of 
these compounds are scarce. The presence of coumarin in fungi has been established in most 
genera of Xylariaceae family (Ascomycetes) (Whalley et al., 1999), as well as in certain fungi 
belonging to lignicolous basidiomycets based on preliminary TLC profiling (Karaman, 
2002). 
Other agents with weak antibacterial effects found in macrofungi are steroids like 5α-
ergosta-7,22-dien-3β-ol or 5,8-epidioxy-5α,8α-ergosta-6,22-dien-3β-ol, isolated from 
Ganoderma applanatum (Pers.) Pat., proved to be weakly active against a number of Gram-
positive and Gram-negative bacteria and organic acids like oxalic acid proved to be 
responsible for the antibacterial effect of Lentinula edodes (Berk.) Pegler against S. aureus and 
other bacteria. 
Other, non-phenolic, compounds including terpenoids (Leon et al., 2004) and 
polysaccharides (Tseng et al., 2008) have also been designated as mushroom antioxidants or 
antimicrobials.  
1.5.2.2 Terpenoid compounds  
Terpenes are a broad class of lipophilic secondary metabolites whose general chemical 
structure is C10H16. In nature they appear as diterpenes, triterpenes and tetraterpens 
(carotenoids) - C20, C30, C40, as well as the hemiterpens and sesquiterpens - C5, C15. If include 
additional elements (mostly oxygen within the hydroxyl and carbonyl groups), they are 
called terpenoids (Cowan, 1999). Terpenoids originate from simple acyclic compounds, 
isoprene and mevalonic acid, and their structure may be acyclic, monocyclic or bicyclic. 
Basically, their structure is isopentenyl-pyrophosphate (IPP), whose synthesis is realized in 
two ways, and pathways of synthesis of higher isoprenoids continue on after the 
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isomerization of IPP in DMAPP. For all animal and fungal cells characteristic is the 
mevalonic pathway of isopentenyl-pyrophosphate synthesis, while most plants, bacteria, 
actinomycetes and protozoa have non-mevalonic mode of its synthesis (Inouye et al., 2004). 
One of the many functions of these compounds is their antimicrobial activity, but the 
mechanism of action of terpenoids on microorganisms is not fully understood (Cowan, 
1999). According to their lipophilic nature, it is assumed to act by disrupting membrane 
functions of microbial cells (Cowan, 1999), and some authors believe that they may cause 
increasing of non-specific cell membrane permeability for the antibiotic molecule (Byron et 
al., 2003). Though plant organisms are thought to be the largest source of triterpenoids, in 
recent years more and more data indicate the presence of these compounds in some 
representatives of macrofungi (He et al., 2003, Akihisa et al., 2005; de Silva et al., 2006; 
Abraham, 2001, Deyrup et al., 2007). 
Sesquiterpenes. One of the many strategies that representatives of the higher fungi use to 
protect themselves against a number of parasites that feed on their fruit bodies is the 
production of toxins. It is interesting that many of these toxic chemical suits sesquiterpens 
(Abraham, 2001). For most basidiomycota fungi the presence of sesquiterpens of 
protoiludane type is characteristic, which originate from humulene, compounds present in a 
rare fungus, formed by cyclization of farnesyl-pyrophosphate. Of the few ways of humulene 
transformation, the most important pathway of synthesis of protoiludane, tricyclic 
compound which, due to the high reactivity caused by the presence of cyclobutane, is 
further transformed into a series of compounds. Some of these sesquiterpenes show 
interesting biological activity, and are considered to be a very interesting object of study in 
terms of medical chemistry. Several groups of sesquiterpenes originating from higher fungi 
show a greater or lesser antimicrobial effect (Tables 2, 3). It is interesting to note that some 
representatives of the genera Russula and Lactarius synthesize sesquiterpene alcohols that 
are esterifies with fatty acids. These esters do not show strong antibiotic activity, but in the 
case of mushroom fruit body injury, leads to cleavage of ester bonds and release of alcohols 
that are highly reactive and therefore very toxic to microorganisms. Therefore, the 
mentioned esters may be considered as pro-medicines or precursors of compounds that in 
metabolic processes are transformed into an active form. 
Triterpenes. Compounds of triterpene composition are found in many mushroom extracts 
which showed some antibiotic properties. Genus Ganoderma contains about 200 species 
known for the production of triterpene compounds. Many of these species have found wide 
application in the prevention and treatment of various diseases due to the numerous 
biological activities based on the presence of triterpene components (Ofodile et al., 2005). 
Although thought to be active against bacteria just due to the presence of triterpenes in 
these fungi, there are data that disagree with such opinions, giving the example of seven 
different triterpenes isolated from a Vietnamese species G. collosum, which showed no 
antimicrobial effect, but exhibit strong anti-inflammatory activity (Ofodile et al., 2005). Most 
triterpenes synthesized by species of the genus Ganoderma belong to the lanostane type (de 
Silva et al., 2006). Over 100 compounds from this group have been identified, among them a 
few newly discovered (Akihisa et al., 2005; de Silva et al., 2006, Jian et al., 2003, Kamo et al., 
2003). The review of triterpene compounds isolated from macrofungi is given in Table 3. 
Overview of other compounds isolated from macrofungi, which exhibit antimicrobial 
activity is shown in Tab. 4 
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COMPOUND 
 
NAME OR CHEMICAL 
STRUCTURE 
ORIGIN EFFECT (ACTIVITY) 
CARYOPHYLLENE Naematolin Hypholoma fasciculare weak antibacterial  
COLLYBIAL 
 
α,β-unasturated 
aldehyde 
Collybia confluens low antifungal, high 
antibacterial (Bacillus sp.), 
high antiviral, cytotoxic, 
nonselective antibiotic 
PROTOILLUDANES
(esters of  
protoilludanol) 
 
Armillyl orselinate  
Arnamiol 
(chlorinated derivatives) 
Melleolide B, C, D,  E, F, 
G, H (everniate-armillarin)
Melleolide I, J 
Radulon A 
Lentinellic acid 
methyl-estars of 
lentinellic acid  
Armillaria mellea
(similar to A. tabescens) 
Clitocybe elegans 
A. novae-zelandiae 
Radulomyces confluens 
Lentinellus 
 
prevent trombocite 
aggregation, cytotoxic,  
antimicrobial 
low antifungal, high 
antibacterial, cytotoxic  
high antifungal , low 
antibacterial 
 
MARASMANES  
 
 
 
Marasmic acid 
hydroxy derivative of 
marasmic acid 
Pilatin 
Velutinal and fatty acid 
esters   
Marasmius conigenus
culture – Flagelloscypha 
pilatii contain many 
Basidiomycota by 
damage of fruiting-
bodies, converting to 
Isovelleral  
antibacterial 
less antifungal, cytotoxic and 
phytotoxic 
lower antibiotic and 
cytotoxic 
high antibacterial, 
antifungal & cytotoxic  
HYDROGRAMMANE
(modified marasmic   
sesquiterpenes) 
10-hydroxy-isovelleral  
Hydrogrammic acid 
Clitocybe hydrogramma antibacterial against 
Bacillus sp., non against E. 
coli and fungi  
CUCUMANES  culture –Macrocystidia 
cucumis  
antimicrobial and 
cytotoxic 
FOMANNOSANES  
 
Fomanosin  
Illudosin  
 
Fomes annosus  
Omphalotus olearius 
Omphalotus nidiformis. 
bactericidal,phytotoxic  
antibacterial against Gram 
+ (Sarcina lutea and Bacillus 
spp.), non against E. coli 
antifungal 
ILLUDANES 
 
Illudin S (lampterol) 
Illudin M 
Hydroxydihydroilludin 
M 
Illudin A, B, C, D i E  
Illudalenol,  
Illudin F, G i H 
Illudin C2 i C3  
Illudinic acid 
Omphalotus olearius 
Lampteromyces 
japonicus, Omphalotus 
olivascens  
Clitocybe subilludens  
Pleurotus japonicus  
Omphalotus olearius 
Omphalotus nidiformis 
Coprinus atramentarius 
Agrocybe aegerita 
anticancerogenic 
properties 
weak antibiotic activity on 
B. subtilis  
cytotoxic, antibiotic  
(S. aureus), antifungal 
ILLUDALANES 
(dicoumaric 
sesquiterpenes) 
 
 
ISOILLUDANES 
Fomajorin D & S 
Illudalic acid  
illudinine 
Candicansol 
Clavicoronic acid 
Leaianafulven 
Fomes annosus  
Omphalotus olearius 
Clitocybe candicans  
Clavicorona pyxidata  
Mycena leaiana 
antiviral (inhibits reverse 
transcriptase of viruses 
causing leukemia in rats 
-weak antibiotic activity   
(Acinetobacter),  high 
cytotoxic, mutagenic  
Table 2. Antimicrobial effects of sesquiterpenoids orginated from macrofungi  
(according to Abraham, 2001) 
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Compound Name or 
chemical 
structure
ORIGIN EFFECT (ACTIVITY)
   HIRSUTANES 
 
 
PLEUROTELANES pleurotelic 
skeleton, created by 
modification of hypnophillin 
  CUCUMANES      
    
 
  
MERULANES  
ISOLACTARANES 
TRITERPENOIDES  
Hirsutic acid  C 
Complicatic acid  
 
Hypnophillin 
Pleurotelic acid 
Pleurotellol 
 
Coriolin A, B, C 
Hypnophillin 
1-desoxyhipnophyilin 
 
 
Gloeosteretriol  
Incarnal  
(dehydro-hirsutanol A) 
  
  
Cucumins A-H 
 
 
Merulidial  
 
 
 
 
Meruliolactone 
Stereum hirsutum  
Stereum complicatum - culture  
Pleurotus hypnophilus 
 
Coriolus consors 
 
Lentinus crinitus-
 
 
Gloeostereum incarnatum - culture 
 
 
Macrocystidia cucumis 
 
 
Merulius tremellosus - culture 
 
Stereopolide
Dihydrostereopolide 
Stereum purpureum – culture,  
Merulius tremellosus 
TRITERPENES  Lanostane-type G. applanatum
G lucidum
(de Silva et al., 2006)
 Lanostane-type, 
fatty acids  
lanostane and 
ergostane derivatives 
Fomes
Triterpenoid lactons  Fomlactons A, B, C Fomes cajanderi
Triterpenic glycosides 
 
 
 
Kolocosides A, B, C, D 
 
Fuscoatroside 
Enfumafungin -
WF11605 
common in plants and lichens, so far 
only three representatives found: 
Xylaria from Hawaiian Islands 
 
Triterpenoid saponins 
 
glycosides with betulin 
as a aglyconic 
component 
P. ostreatus
 Favolon  
(with variable cyclic 
structure and method 
of substitution) 
Favolaschia
 
Table 3. Antimicrobial effects of sesquiterpenoids and triterpenoids from macrofungi 
(according to Abraham, 2001) 
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1.6 Extraction methods  
Extraction procedures are important in assessing good antibacterial activities of extracts. 
Macrofungi are commonly collected either randomly or by locals in geographical areas or 
forest habitats where the fruiting bodies are found. Initial screenings of fungi for possible 
antibacterial activities usually begin by using crude aqueous or alcohol extractions. Since the 
majority of the identified components of mushrooms are active against microorganisms, 
they are mostly obtained through initial ethanol or methanol extraction.  
Water-soluble compounds, such as polysaccharides and polypeptides, including lectins, are 
commonly more effective as inhibitors of virus adsorption and cannot be identified in the 
screening techniques commonly used. Tannins and terpenoids are occasionally obtained by 
treatment with less polar solvents. 
For alcoholic extraction, the intact mature fruiting bodies or their segments are brush 
cleaned, air-dried to constant mass and pulverized, and then soaked in methanol or ethanol 
for extended periods (24-72h). The resultant filtrated extracts are then filtered and washed, 
concentrated under reduced pressure at low temperature to avoid destroying of any 
thermo-labile antimicrobial agents present in the extract and redissolved in the alcohol (or 
5% DMSO) to a determined concentration. Water extractions, generally used distilled water, 
blending of slurry, filtration and centrifugation (approximately 15,000 for 30 min) multiple 
times for clarification.  
Compounds Origin/Source Biological activity Reference 
β-methoxyacrylates 
strobilurins and oudemansins 
cultures of 
Oudemansiella 
mucida, Xerula 
malanotricha and 
Xerula longipes 
- antifungal activity against a
large number of 
saprotrophic and 
phytopatogenic fungi, 
inhibiting the process of 
respiration 
Anke et al.,  1979; 
Anke et al., 1983 
Polyenes  
xerulin, dihydroxerulin and  
xerulinic acid 
Xerula malanotricha 
- antimicrobial, anticancer,
antiviral and anti-
inflammatory activity  
- inhibition of cholesterol 
biosynthesis and cytotoxic 
effect 
Negishi et al., 
2000;  
Kuhnt et al., 1990 
Agrocybolacton 
cultures of 
representatives of 
the genus Agrocybe  
- moderate antibacterial
activity against Gram-
positive bacteria B. subtilis 
and M. smegmatus 
Rosa et al., 2003 
Lentionine 
 (1,2,3,5,6-
enthatiocyclocheptane) and its 
disulfide derivate 
Lentinus edodes 
antibacterial  
antifungal effect  
Hirasawa et al., 
1999) 
Cinnabarine 
Pycnoporus 
cinnabarinus 
antibacterial          
(B. subtilis S. aureus)   
antifungal effect  
Shitu et al., 2006 
Laschiatrion  
new antibiotic with steroid 
skeleton 
submerged cultures 
of the genus 
Favolaschia 
- in vitro antifungal activity
against some human 
pathogens 
- antibacterial and citotoxic 
effects not detected 
Anke et al., 2004 
Table 4. Other compounds from macrofungi with antimicrobial activity  
 
Antimicrobial Agents 
 
376 
1.7 Evaluation of antibacterial activity  
1.7.1 Techniques used in research of new substances 
Basidiomycota and fungi in general, represent an inexhaustible source of new substances, 
even though each species contains hundreds of active metabolites. Therefore, test systems 
for research of new substances must be fully simplified, fast, efficient and as cheap as 
possible (Hostettmann et al., 1997, as cited in Giovaninni, 2006). In addition, biotests 
(bioassays) must be sufficiently sensitive to detect the activity of substances in low 
concentrations, in the so-called solid (crude) extracts. 
Crude products can be used in antimicrobial testing disc-diffusion and broth-dilution assays 
to test for antibacterial properties including bioautography according to standard 
procedures (NCCLS or CLSI procedures). The use of standard cultures of familiar 
characteristics is recommended though several precautions have to be taken into account. In 
a recent study the differences between two screening methods applied were not statistically 
significant (t-test at level p< 0.05). Both Meripilus extracts analyzed (water and methanol) 
showed wider inhibition zones in disc-diffusion method, indicating that it is more 
appropriate for the testing of polar extracts (Karaman et al., 2009b).  Similar results were 
confirmed for extracts of the genus Fomes although showed broader inhibitory zones using 
the method of "wells", compared with inhibitory zones obtained by disc-diffusion method. 
For other extracts, however, the disk-diffusion method could be recommended, indicating 
that polarity of active substances in extract influence on results obtained in particular 
method applied.  
MIC and MBC determination is used to quantify antimicrobial activity using the two-fold 
dilution method according to CLSI guidelines. The MIC is defined as the lowest 
concentration preventing visible growth while complete absence of growth is considered as 
the MBC. The lower MIC or MBC values with respect to the extract concentration indicate a 
higher activity, implying better quality of the extract. To confirm MBCs, aliquots of the 
experimental suspensions (100μl) could be sub-cultured on Müeller Hinton agar plates 
incubated overnight.  
Potent source of antibacterial agents is the species M. giganteus (50mg/ml), showing high 
activity against both groups of bacteria reaching MIC values in a wide range of 
concentrations (<17.5 -1125μg/ml). Various activities have been detected among different 
strains of S. aureus, indicating that fungal extracts are target specific on intraspecific level 
(strain specific).   
Antibacterial assay may be performed in 96-well micro-plates instead of tubes. If 5% DMSO 
is applied for dissolving a negative control with 0.5% DMSO must be used to ensure that 
DMSO did not affect bacterial growth. Results are recorded after incubation at 35-37ºC for 
18-24h and all the samples should be tested in triplicate. 
Bioautography is one of the most effective tests for detection of antimicrobial metabolites, 
considering the fact that it localizes the place of the active component, therefore enabling the 
isolation of the active component precisely. Bioautography may be the direct, when 
microorganisms grow directly on the TLC plate, then contact, when the active compound is 
transferred from the TLC plates to inoculated agar and agar-spill-over (so-called immersion 
bioautography), when the inoculated agar medium is spilled over the TLC plate (Rahalison 
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et al., 1991). In the bioautography agar overlay method, the drug to be evaluated is adsorbed 
onto the TLC plate and the inoculum is laid onto the plate as a very thin layer (1 mm). The 
advantage of this method is that the amount of sample being used is very small and that the 
fractionalisation of the crude extracts on its different components simplifies the 
identification of active compound.26  
In our recent work, the  TLC chemical profile of the analyzed species of lignicolous 
macrofungi showed that they are rich in phenols, although the differences in the number 
and quality of the extracted compounds have been noticed. Comparing the TLC profiles, 
fungi can be classified into three groups according to the obtained retention factor e.g. Rf 
values representing   the distance traveled by the compound divided by the distance 
traveled by the solvent: 1) three species: C. versicolor, G. lucidum and G. applanatum contain 
compounds with similar (Rf = 0.68, Rf = 0.69, Rf = 0.70, respectively), 2) five species M. 
giganteus, L. sulphureus, F. velutipes, F. hepatica and P. ostreatus showed a small amount of 
eluated compounds and intense fluorescence at the start line after the spraying, 3) the 
species P. betulinus expressed with three spots in the MeOH extracts (Rf = 0.62, Rf = 0.65,  
Rf = 0.68), which extinguished fluorescence in the UV 254th (Karaman, 2009c).  
Furthermore we made slight modifications of the standard procedure of bioautography in 
the same study using the following: soft (top) agar (0.7% Nutrient agar) which was mixed 
with freshly prepared inoculum of bacteria (0.5Mac Farland optical density) and with the 
aqueous solution of tetrazolium red dye 0.1% w/v (1mg/ml)- 2,3,5-triphenyltetrazolium 
chloride (TTC, Sigma) (3:1:0.1). The strain S. aureusan was used as the indicator organism. 
Amoxicillin (64µg/ml) was used as positive control. Approximately 10µl of the solution of 
each extract was applied on a TLC plates (silica gel 60, F 254, DC-Plastikfolien, 0.2 mm thick, 
Merck, Germany) for about 2h, equally prepared as a reference plate for chemical analysis. 
Bioautography test plate was developed in the same tank using the pre-determined mobile 
phase which was removed from the plate by drying with a stream of cool air from a heating 
gun. Separated spots were visualised under UV light and marked by pencil (Figure 2A). 
Developed plates were placed upside-down in the petri dishes containing bottom agar 
(nutrient agar, Torlak, Belgrade). Soft agar (07% Nutrient agar) was melted and poured into 
sterile tubes (100 ml) in which the dye and bacteria were added quickly. That mixture was 
flowed over the chromatograms in the petri dishes. After the agar has solidified, the plates 
were inverted and incubated at 35ºC for 24h. The clear zones on the chromatogram indicate 
areas of inhibition zones on the red background where bacteria are present. Comparing 
clearing zones with reference TLC plate according to Rf values the most active components 
of crude fungal extracts could be approximately detected (Fig. 1B).  
Bioautography results showed many antibacterial compounds against animal strain of S. 
aureus that were mostly present in the polar region of the bioautogram. According to 
detected clearing zones, chloroform extracts were more active corresponding to more 
detected UV absorptive substances along the chromatogram. However, these substances 
were not active in methanolic extracts on bioautogram for C. versicolor and P. betulinus.   
Developing system: toluene-ethyl acetate – 90% formic acid (5:4:1 v/v/v). Detection: 366 
nm UV light without spraying. Extracts: lane 1- M. giganteus (MeOH), lane 2- L. sulphureus 
(MeOH), lane 3- C. versicolor (MeOH), lane 4- F. velutipes (MeOH), lane 5- G. lucidum (EtOH), 
lane 6- G. applanatum (MeOH), lane 7- P. tigrinus (MeOH), lane 8- P. betulinus (MeOH), lane 
9- P. ostreatus (MeOH), lane 10- F. hepatica (MeOH), lane 2´- L. sulphureus (CHCl3),  
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lane 3´- C. versicolor (CHCl3), lane 4´- F. velutipes (CHCl3),  lane 6´- G. applanatum (CHCl3), 
lane 7´- P. tigrinus (CHCl3), lane 8´- P. betulinus (CHCl3) B: Bioautogram of extracts for S. 
aureusa. Extracts: lane 1- M. giganteus (MeOH), lane 2- L. sulphureus (MeOH), lane 4- F. 
velutipes (MeOH), lane 3- C. versicolor (MeOH), lane 6- G. applanatum (MeOH), lane 5- G. 
lucidum (EtOH), lane 7- P. tigrinus (MeOH), lane 8- P. betulinus (MeOH), lane 9- P. ostreatus 
(MeOH), lane 10- F. hepatica (MeOH), lane 2´- L. sulphureus (CHCl3), lane 3´- C. versicolor 
(CHCl3), lane 4´- F. velutipes (CHCl3),  lane 6´- G. applanatum (CHCl3), lane 7´- P. tigrinus 
(CHCl3), lane 8´- P. betulinus (CHCl3). 
 
 
Fig. 1. A: TLC separation of crude extracts (methanol - MeOH and chloroform - CHCl3) of 
selected lignicolous species prepared for bioautography assay and B: bioautogram of 
extracts for Gram- positive bacteria S. aureus, animal strain  
1.8 Target organisms 
Bacillus subtilis is a Gram + bacteria, non-pathogenic to humans and can be used as a 
model organism in similar tests, since the representative of the same genus, bacteria B. 
anthracis is responsible for the disease anthrax, which is characterized by the appearance of 
edema, hemorrhage and tissue necrosis. It is common in some animals, often used as a 
biological weapon in bioterrorism. If an extract shows activity against B.subtilis, it is possible 
to be active against B. anthracis and possibly against other pathogenic Gram + bacteria such 
as specieses of the genera Staphylococcus and Streptococcus. 
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Escherichia coli. E. coli, Gram - bacteria, inhabits the gastro-intestinal tract of humans and 
warm-blooded animals, making their normal indigenous microflora. In immuno-suppressed 
patients, however, it can cause infections, sometimes fatal (Giovannini, 2006). Gram - 
bacteria cause more problems than Gram +, as a result of their different cell wall structure. 
Since penicillin and cephalosporin antibiotics belong to the group that act at the level of cell 
wall synthesis, the exploration of new types of antibiotics is very important for group of Gr- 
organisms. 
C. albicans belongs to Deuteromycota, representing yeasts forming pseudo-mycelia. It lives 
as a part of the normal human microflora, especially in the mucosa of the mouth and vagina. 
In immuno-suppressed individuals (AIDS, chemotherapy, inadequate nutrition and poor 
hygiene), or after prolonged use of antibiotics, it can cause disease called candidiasis, which 
is the most common caused by C. albicans as the most widespread species. It may affect 
almost any tissue, starting with simple children’s thrush, and ending as the systemic 
infections. Most commonly it is manifested in the form of slimy mucus. C. albicans, is very 
convenient target organism in the detection of new antifungal drugs. 
2. Determination of active substances  
In the last decades of the 20th century, the study of macrofungi was intensified, including 
the research of structurally different metabolites (polysaccharides, glycoproteins, proteo-
glucans, terpenoids, fatty acids, proteins, lectins, etc..) originating from the primary or 
secondary metabolism of fungi, as well as different biological activities that they express. 
Metabolites from fungal fruit bodies or spores themselves are substantially different from 
those that come from extracellular liquid of the medium in which submerged mycelium was 
grown or from cells of the culture. Since the phenomenon of multidrug-resistance of 
microorganisms is on the rise, the studies of macrofungi increased in range, in spite of the 
fact that they are very slow growing organisms. The value of macrofungi and the dietary 
supplements, originating from these organisms, grows each year on the world market. They 
are very safe and considered as the factors useful in the daily diet, especially for people 
suffering from various diseases. 
Natural-products chemists further purify active chemicals from crude extracts by a variety 
of methods. The chemical structures of the purified material can then be analyzed. 
Techniques for further chemical analysis include chromatography, bioautography, 
radioimmunoassay, various methods of structure identification, or modern techniques such 
as atom bombardment mass spectrometry, Gas chromatography–mass spectrometry, high-
performance liquid chromatography, capillary zone electrophoresis, nuclear magnetic reso-
nance spectroscopy, and X-ray crystallography.  
3. Conclusion 
The presented results indicate that extracts from lignicolous macrofungi could be used in 
the prevention and treatment of Gram-positive bacterial infections resistant to antibiotics in 
animals (humans), although further toxicity assays (in vivo) must be performed before its 
application. The fact that fungi can have bactericidal properties with low cytotoxicity to the 
animal host underscores their usefulness as natural sources of human or veterinary 
medicines. 
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Also, the results obtained should stimulate further studies of other, so far unexplored, species 
such as M. giganteus and P. tigrinus, since current knowledge of the antibacterial activities or 
chemical composition of their active agents is not capable of fulfilling the expectations. 
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